08:00 - 09:00

Registration, networking and exhibition visits

09:00 - 09:10


  • Welcome and introduction

    Gwyn Tudor

09:10 - 10:00

Plenary session


    John Wilkinson
    Director of Devices

    New Regulations: The way ahead

    Bill Cruise
    3M Healthcare
    Vice President, Western Europe 3M and Medilink UK Chair

    Innovation in the Healthcare Sector - some thoughts and experiences

10:00 - 10:30

Refreshment break, networking and exhibition visits

10:30 - 11:30

Parallel session
Early Access to Medicine - A streamlined approach to clinical development

The Accelerated Access Review has announced further support for a funded Early Access to Medicines Scheme designed to speed up access to innovative drugs. Presentations on the increasingly important debate about patient access to new medicines, the clinical development process and the benefits of a streamlined approach to allow innovation in medicines.

  • Chair

    Professor Sue Bale OBE
    Aneurin Bevan University Health Board
    Research and Development Director

  • Seshadri Vasan
    Public Health England
    Senior Business Development Manager

    From Ebola to Zika: Accelerating pre/clinical development of repurposed and new countermeasures during emergencies

    Chris Harbach
    Validation Manager, Life Sciences

    Extractables and Leachables Analysis

    Shaun Stapleton
    Head of Regulatory Affairs

    The route to approval in a new indication

10:30 - 11:30

Parallel session
The Impact of regulatory changes

The latest developments regarding the Medical Device and IVD Directives. Discussing the impact on your business and the management of innovation within these new directives.

  • Chair

    John Wilkinson
    Director of Devices

  • Richard Saunders
    Ortho-Clinical Diagnostics
    International Regulatory Affairs Senior Manager

    Medical Device Regulations – An Industry Perspective

    Erica Conway
    BSI Group
    Head of IVD

    Impacts of the new IVD Regulation – a Notified Body’s perspective

    Michael Branagan-Harris
    Device Access UK

    How to accelerate adoption for your MedTech Device into NHS England

    Stuart Johnson
    Business Development Executive

    Medical Regulations Market View

11:30 - 12:30

Parallel session
Market Access - UK procurement and an update on innovation initiatives

Update on the procurement landscape in the UK and challenges facing companies supplying the NHS. Discuss engagement with the NHS, the latest innovation adoption initiatives, the implementation of the Carter report and the results of the Accelerated Access Review.

  • Chair

    Andrew Davies
    Market Access Director

    Activities & Issues in Medtech

  • Naomi Chapman
    NHS Clinical Evaluation Team, Department of Health
    Clinical Programme Lead/Deputy Chief Nurse

    The NHS Clinical Evaluation Team (England) – By the NHS, for the NHS

    Phil Bailey
    Industry Engagement Manager, Healthcare

    How global standards support the healthcare industry

    Chris Doyle
    Genshone Transformation Ltd
    Managing Director

    eProcurement and Serialisation - Master Data is the key

11:30 - 12:30

Parallel session
Innovation Showcase

New technologies and growth companies


    Michael Graz
    Neem Biotech
    Managing Director

    Scale up and keep your balance

    Andrew Mearns Spragg

    Jellyfish Collagen Biomaterials - Next generation collagen for cell culture and med-tech products

    Mark Bowman

    Using Infra-red Spectroscopy to Detect and Monitor Chronic Obstructive Pulmonary Disease

    Sumi Thaker
    Momentum Bioscience
    Commercial Director

    Revolutionising Routine Sepsis Diagnostics

    Shaun Philips
    BBI Solutions
    Senior New Product Development Scientist

    BBI Solutions: Shaping the future of lateral flow technology

    Wayne Harris
    Huntleigh Diagnostics
    Business Unit Manager

    Applying advanced technologies to the management of Lymphoedema

12:30 - 13:30

Lunch break, networking and exhibition visits

13:30 - 14:30

Plenary session


    Shahid Hanif
    ABPI - Association of the British Pharmaceutical Industry
    Head of Health Data and Outcomes

    Industry perspectives on health data and patient outcomes

    David Sheppard
    Department of International Trade
    Head of Trade, Life Sciences Organisation

    What the Department of International Trade can do for you and priorities for the next five years

    Peter Whittington
    Office for Life Sciences
    Assistant Director

    The Accelerated Access Review – accelerating access to innovative medical technologies and medicines for NHS patients

    Emma Titmus
    London Stock Exchange
    Business Development Manager

    How to Finance High Growth

14:30 - 15:30

Parallel session
Healthcare innovation and patient safety

The NHS is slow to change and adopt new techniques and treatments. Discussing the assessment and promotion of adoption of innovative technologies, the patient perspective and showcase of innovation adoption initiatives.

  • Chair

    Ifan Evans
    Welsh Government
    Head of Healthcare Innovation

    NHS Wales approach to innovation and technology adoption

  • Peter Groves
    National Institute for Health and Care Excellence (NICE)
    Chairman, Medical Technologies Advisory Committee

    The Role of NICE in the Evaluation of Innovative Medical Technology

    Chris Gibson
    Smartgate Solutions
    Strategic Organisational Development & Innovation

    Healthcare innovation & patient safety adopting new techniques and innovation

    Damian Bridgeman
    Business Developement Manager UK and Europe

    Lets get comfortable - A patient perspective

14:30 - 15:30

Parallel session
New diagnostics, precision medicine and advanced therapies

A revolution in healthcare treatments is just around the corner. What does the future of healthcare look like and what are the barriers to delivering new therapies from research into clinic and practice?

  • Chair

    Paul Smith
    Director of Science

    Precision Medicine in the Microenvironment

  • Daryl Fernandes
    Chief Executive

    Precision Medicine at Ludger: Glycomics, patient stratification and fat bellies

    Paul Seaman
    Midatech Pharma
    Head of Sustained Delivery

    Right Time, Right Place; Exploiting Micro and Nano Particulates for Drug Delivery

    Fred Jacobs

    Targeting cancer at every stage

15:30 - 16:00

Refreshment break, networking, exhibition visit

16:00 - 17:00

Parallel session
Support and funding for commercialisation and R&D

Funding for research, new product development and clinical trials. Case studies and success strategies.

  • Chair

    David Calder
    The Knowledge Transfer Network
    Knowledge Transfer Manager Health and Care

    Landscape Update - KTN and Innovate UK Support to Businesses

  • Chris Rowe
    Innovate UK
    Lead Technologist - Stratified Medicine Innovation Platform

    Innovate UK: Health and Life Sciences Sector

    Martin McHugh
    Technology and Business Development Manager

    Leveraging R&D Funding

    Corinne Squire
    South East Wales Academic Health Science Partnership (SEWAHSP)

    Support for joint working with NHS and Academia

16:00 - 17:00

Parallel session
The Future of Digital Health

The potential for the transformation of NHS systems and the patient experience by digital technologies is enormous. Exploring the progress in delivering on the digital and data revolution.

  • Chair

    David Ford
    The Farr Institute
    Deputy Director

  • Phil Sinclair
    Partner, Philips Healthcare Transformation Services

    Transforming the patient journey through connected care.

    Jose Fortino
    Patient Monitoring and Connected Care Business Manager

    Dyfan Searell
    Elidir Health

    Realising mobile digital for the NHS - delivering a Connected Healthcare Administration Interface through co-production

    David Halliwell
    MDT Global Solutions
    Managing Director

    Developing Innovative Education

    Adrian Stavert-Dobson
    Safehand Consulting Limited
    Clinical Safety Officer

    Designing and implementing health IT systems safely

17:00 - 17:30

Final Panel
Brexit and an 'Industrial strategy' for business

What does Brexit mean for your company, investment and growth strategies?

  • Chair

    Gwyn Tudor

  • Phil Barnes
    Finance Wales
    ‎Investment Executive

    Shaun McBride
    Elite Electronic Systems
    Medical Business Development

    Peter Whittington
    Office for Life Sciences
    Assistant Director

    Melanie Goward
    Maven Capital Partners
    Investment Director

    David Sheppard
    Department of International Trade
    Head of Trade, Life Sciences Organisation

17:30 - 19:00

Event close and drinks reception
Sponsored by Neem Biotech

Please be aware that speakers and timings may change prior to the event.